Target intelligence / Profile preview

Small RNA binding exonuclease protection factor La like 5, pseudogene (SSBL5P)

Target
SSBL5P
Molecular classification
Other: Pseudogene
01

Overview

SSBL5P (Small RNA binding exonuclease protection factor La like 5, pseudogene) is a human pseudogene with high sequence similarity to the SSB (Sjogren syndrome antigen B) gene but is considered nonfunctional (not producing an active protein)[3][5][8]. Pseudogenes like SSBL5P often arise from reverse transcription events resulting in processed or unprocessed noncoding gene fragments integrated into the genome[6][8]. While most pseudogenes do not carry out biological functions, some can act as regulators at the RNA level, such as miRNA decoys, endogenous siRNA sources, or indirectly modulating gene expression[2][4][9]. For SSBL5P, no specific regulatory or pathological function has been described, and it is absent from lists of known drug targets or disease biomarkers[3][5][8].

Other names
SSB like 5, pseudogeneSjogren syndrome antigen B pseudogeneSmall RNA binding exonuclease protection factor La pseudogeneSSBL5P
02

Mechanism of action

None known or reported—pseudogenes such as SSBL5P do not have targetable activity suitable for pharmacologic intervention.

03

Biological functions

No direct biological functions are attributed to SSBL5P itself in current databases or literature.Pseudogenes can occasionally participate in regulatory functions or RNA-mediated mechanisms, such as potential decoys for miRNAs.In some cases, pseudogenes can affect gene expression via RNA interference pathways.No specific function has been documented for SSBL5P in humans.
04

Disease associations

For SSBL5P specifically, there are no documented direct roles in disease.For pseudogenes more broadly, there is emerging evidence that some pseudogenes can regulate gene expression, sometimes implicated in cancer or developmental processes via regulatory RNAs.There is no concrete evidence for a direct SSBL5P involvement.
05

Safety considerations

None reported for SSBL5P as it is genomically encoded, nonfunctional as a protein, and there is no evidence it functions as an RNA with pathological roles.

Beyond the preview

Go deeper on Small RNA binding exonuclease protection factor La like 5, pseudogene (SSBL5P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small RNA binding exonuclease protection factor La like 5, pseudogene (SSBL5P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call